Scientific work

Prof. Dr. Özlem Ercelep

90 publications. The source of the information is stated next to each publication.

Back to profile

  1. Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS study

    Nutrition, 2026

    DOI 10.1016/j.nut.2025.113029 PMID 41455457 1 citation (Europe PMC) Source: ORCID

  2. Prognostic Factors in Advanced Bladder Cancer: A Real-World Retrospective Analysis

    Haydarpaşa Numune medical journal (Online), 2026

    DOI 10.14744/hnhj.2026.82997 Open-access full textSource: OpenAlex

  3. Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14062024 PMID 40142832 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Oncological perspective on Kaposi sarcoma: A single-centre experience

    Marmara Medical Journal, 2025

    DOI 10.5472/marumj.1627569 Open-access full textSource: ORCID

  5. Colorectal Cancer Metastasizing to the Thyroid Gland: A Rare and Interesting Case

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-3-11 Open-access full textSource: OpenAlex

  6. Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.

    PubMed Central, 2025

    DOI 10.5144/0256-4947.2025.18 PMID 39929787 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. Denovo Metastatic Primary Gastric Ewing Sarcoma/Primitive Neuroectodermal Tumor– 13 Years Follow-up: Case Report and Review of Literature

    Journal of Medicine and Medical Studies, 2025

    DOI 10.51219/jmms/guren-ak/19 Open-access full textSource: OpenAlex

  8. Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups

    Future Oncology, 2025

    DOI 10.1080/14796694.2025.2567845 PMID 41047636 Open-access full textSource: OpenAlex

  9. The Effect of PET/CT SUV max Value on Anti-EGFR Treatment Response in Lung Adenocarcinoma

    International Journal of Hematology and Oncology, 2025

    DOI 10.4999/uhod.257838 Open-access full textSource: OpenAlex

  10. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 citations (Europe PMC) Source: OpenAlex

  11. Evaluating the performance of the MSKCC gastric cancer survival calculator in the Turkish population

    Turkish journal of medical sciences, 2024

    DOI 10.55730/1300-0144.5901 PMID 39734332 Open-access full textSource: Europe PMC

  12. Prognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapy

    Indian journal of cancer, 2024

    DOI 10.4103/ijc.ijc_649_21 PMID 39960709 Open-access full textSource: Europe PMC

  13. Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study

    Biomolecules and Biomedicine, 2024

    DOI 10.17305/bb.2024.10512 PMID 38920621 1 citation (Europe PMC) Open-access full textSource: ORCID

  14. Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e20512 Open-access full textSource: OpenAlex

  15. Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

    Bursa Uludag University - AVESIS, 2024

    Source: OpenAlex

  16. Alterations in muscle strength among patients with GI cancers receiving oral nutritional support as soon as malnutrition was detected: ONMUS study.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.3_suppl.741 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  17. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

    The Oncologist, 2023

    DOI 10.1093/oncolo/oyad257 PMID 37676712 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  18. Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group

    Cancers, 2023

    DOI 10.3390/cancers15061667 PMID 36980554 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  19. Abstract P3-02-06: Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group

    Cancer Research, 2023

    DOI 10.1158/1538-7445.sabcs22-p3-02-06 Source: OpenAlex

  20. PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score

    Journal of Clinical Medicine, 2023

    DOI 10.3390/jcm12196420 PMID 37835062 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  21. Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma

    Indian journal of cancer, 2023

    DOI 10.4103/ijc.ijc_1049_20 PMID 36861712 8 citations (Europe PMC) Open-access full textSource: Europe PMC

  22. Results of surgical treatment of pulmonary artery sarcomas: Does histology affect survival?

    Turk gogus kalp damar cerrahisi dergisi, 2023

    DOI 10.5606/tgkdc.dergisi.2023.23906 PMID 37664762 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  23. Prognostic Significance of Mucinous Histology in Metastatic Colorectal Cancer Patients Treated with Regorafenib

    Journal of Oncological Science, 2023

    DOI 10.37047/jos.2022-94250 Open-access full textSource: ORCID

  24. Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters

    Acta Radiologica, 2023

    DOI 10.1177/02841851221140504 PMID 36447438 2 citations (Europe PMC) Source: ORCID

  25. L’indice de comorbidité de Charlson ajusté selon l’âge est un outil pronostique précieux dans le sarcome des tissus mous opérable du tronc et des extrémités

    Revue de Chirurgie Orthopédique et Traumatologique, 2023

    DOI 10.1016/j.rcot.2022.11.016 Source: OpenAlex

  26. Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy

    Future oncology (London, England), 2022

    DOI 10.2217/fon-2021-1322 PMID 35695547 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  27. Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma

    Balkan medical journal, 2022

    DOI 10.5152/balkanmedj.2021.21122 PMID 34928235 7 citations (Europe PMC) Open-access full textSource: Europe PMC

  28. Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma

    Nutrition and Cancer, 2022

    DOI 10.1080/01635581.2022.2063349 PMID 35416100 3 citations (Europe PMC) Open-access full textSource: ORCID

  29. The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

    Journal of Cancer Research and Clinical Oncology, 2022

    DOI 10.1007/s00432-022-04055-5 PMID 35616728 22 citations (Europe PMC) Open-access full textSource: ORCID

  30. The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

    Scientific Reports, 2022

    DOI 10.1038/s41598-022-20056-3 PMID 36192500 15 citations (Europe PMC) Open-access full textSource: ORCID

  31. Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy

    Revista Espanola de Medicina Nuclear E Imagen Molecular, 2022

    DOI 10.1016/j.remn.2021.04.003 Source: ORCID

  32. Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment

    Annals of Nuclear Medicine, 2022

    DOI 10.1007/s12149-022-01785-x PMID 35997890 9 citations (Europe PMC) Open-access full textSource: ORCID

  33. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities

    Orthopaedics & Traumatology Surgery & Research, 2022

    DOI 10.1016/j.otsr.2022.103491 PMID 36455864 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  34. Impact of prognostic nutritional index on survival in recurrent glioblastoma

    Neurocirugía (English Edition), 2022

    DOI 10.1016/j.neucie.2020.11.004 PMID 34998488 4 citations (OpenAlex) Source: OpenAlex

  35. The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers

    Namık Kemal Tıp Dergisi, 2022

    DOI 10.4274/nkmj.galenos.2021.52714 Open-access full textSource: OpenAlex

  36. Onkolojide Palyatif Bakım ve Yaşam Sonu Desteği

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1755 Source: OpenAlex

  37. A rare case of gastric cancer with bilateral breast metastasis during pregnancy

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/1078155220925156 PMID 32448025 8 citations (Europe PMC) Source: ORCID

  38. Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2021

    DOI 10.1016/j.remnie.2021.05.007 PMID 35577492 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  39. Clinicopathological Features, Treatment Outcomes, and Prognostic Factors in Adrenocortical Carcinoma: A Single-Center Experience

    Journal of Oncological Sciences, 2021

    DOI 10.37047/jos.2021-84514 Open-access full textSource: OpenAlex

  40. Küçük Molekül Tirozin Kinaz İnhibitörleri; EGFR Hedefli Tedaviler (Erlotinib, Afatinib, Gefitinib, Osimertinib, Dakomitinib, Lapatinib)

    Turkiye Klinikleri Medical Oncology - Special Topics, 2021

    Source: OpenAlex

  41. Impact of prognostic nutritional index on survival in recurrent glioblastoma

    Neurocirugía, 2021

    DOI 10.1016/j.neucir.2020.11.005 PMID 33454185 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  42. P47.14 Clinicopathologic Features of Large Cell Neuroendocrine Carcinoma of Lung

    Journal of Thoracic Oncology, 2021

    DOI 10.1016/j.jtho.2021.01.870 Open-access full textSource: OpenAlex

  43. Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220920684 PMID 32349641 5 citations (Europe PMC) Source: OpenAlex

  44. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma

    Tumori Journal, 2020

    DOI 10.1177/0300891620950475 PMID 32878562 5 citations (Europe PMC) Source: OpenAlex

  45. Opere Erken Evre Akciğer Kanseri Hastalarında Prognostik Faktörler Retrospektif Tek Merkez Sonuçları

    Namık Kemal Tıp Dergisi, 2020

    DOI 10.37696/nkmj.715690 Open-access full textSource: OpenAlex

  46. Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer

    Turkish journal of obstetrics and gynecology, 2020

    DOI 10.4274/tjod.galenos.2020.90699 PMID 32850187 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  47. PTK-7 Expression in Gastric Cancer: A Prognostic Determinant

    Balkan medical journal, 2020

    DOI 10.4274/balkanmedj.galenos.2019.2019.8.12 PMID 31820857 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  48. QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100594 PMID 32505368 6 citations (Europe PMC) Source: ORCID

  49. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer

    Nutrition and Cancer, 2020

    DOI 10.1080/01635581.2020.1749290 PMID 32270713 62 citations (OpenAlex) Source: OpenAlex

  50. VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100568 PMID 32201052 14 citations (Europe PMC) Source: ORCID